|
Volumn 20, Issue 7-8, 2002, Pages 1117-
|
Pediatric AML: Past, present, and future
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMATINIB;
PROTEIN TYROSINE KINASE INHIBITOR;
ACUTE MYELOBLASTIC LEUKEMIA;
ALLOGENIC BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CHILDHOOD CANCER;
EDITORIAL;
HEMATOPOIESIS;
HUMAN;
PRIORITY JOURNAL;
ACUTE DISEASE;
ANTINEOPLASTIC AGENTS;
BONE MARROW TRANSPLANTATION;
CHILD;
CLINICAL TRIALS;
HUMANS;
LEUKEMIA, MYELOID;
PROGNOSIS;
REMISSION INDUCTION;
RISK FACTORS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0036422021
PISSN: 07357907
EISSN: None
Source Type: Journal
DOI: 10.1081/CNV-120005931 Document Type: Editorial |
Times cited : (2)
|
References (0)
|